A novel fusion protein drug for Alzheimer’s disease without inflammatory side effects
Editor Their findings were published on August 4 in Nature Medicine. Although Aduhelm, a monoclonal antibody targeting amyloid beta…
Their findings were published on August 4 in Nature Medicine. Although Aduhelm, a monoclonal antibody targeting amyloid beta…
